comparemela.com

Latest Breaking News On - Briacell therapeutics corp - Page 1 : comparemela.com

Analyzing BriaCell Therapeutics (OTCMKTS:BCTXF) and Applied Therapeutics (NASDAQ:APLT)

Applied Therapeutics (NASDAQ:APLT – Get Free Report) and BriaCell Therapeutics (OTCMKTS:BCTXF – Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, dividends, analyst recommendations and institutional ownership. Earnings & Valuation This table compares Applied […]

New-york
United-states
Canada
Vancouver
British-columbia
Charlesl-wiseman
Isaacb-maresky
Briacell-therapeutics-corp
Therapeutics-inc
Mercury-pharma-group
Applied-therapeutics

BriaCell Therapeutics (NASDAQ:BCTX) Earns "Buy" Rating from HC Wainwright

HC Wainwright reiterated their buy rating on shares of BriaCell Therapeutics (NASDAQ:BCTX – Free Report) in a report published on Friday, Benzinga reports. They currently have a $18.00 price objective on the stock. BriaCell Therapeutics Stock Performance Shares of BCTX opened at $1.44 on Friday. The stock has a fifty day moving average price of […]

Canada
Briacell-therapeutics-corp
Principal-fund
National-bank
Wealth-group
J-harrison-partners-inc
Kj-harrison-partners-inc
Briacell-therapeutics
Free-report
Cell-therapeutics
Get-free-report

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Update

BriaCell Therapeutics Corp. (NASDAQ:BCTXW – Get Free Report) saw a significant decline in short interest in the month of May. As of May 15th, there was short interest totalling 100 shares, a decline of 95.8% from the April 30th total of 2,400 shares. Based on an average daily volume of 41,000 shares, the days-to-cover ratio […]

Nasdaq
Briacell-therapeutics-company-profile
Briacell-therapeutics-corp
Briacell-therapeutics
Get-free-report
Cell-therapeutics
Briacell-therapeutics-daily

HC Wainwright Reiterates "Buy" Rating for BriaCell Therapeutics (NASDAQ:BCTX)

BriaCell Therapeutics (NASDAQ:BCTX – Get Free Report)‘s stock had its “buy” rating reiterated by investment analysts at HC Wainwright in a research report issued to clients and investors on Friday, Benzinga reports. They presently have a $18.00 price objective on the stock. BriaCell Therapeutics Price Performance Shares of NASDAQ:BCTX opened at $1.44 on Friday. The […]

Canada
Principal-fund
Nasdaq
Briacell-therapeutics-corp
Wealth-group
National-bank
J-harrison-partners-inc
Briacell-therapeutics
Get-free-report
Cell-therapeutics
Partners-inc

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024

BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
wallstreet-online.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wallstreet-online.de Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
Philadelphia
Pennsylvania
Chicago
Illinois
Mccormick-place
Vancouver
British-columbia
Canada
American
British
© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.